Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114702471A details a green air-oxidation method for caronic anhydride, replacing hazardous ozone processes to ensure reliable pharmaceutical intermediate supply.
Novel six-step synthesis method offers improved yield and industrial scalability for high-purity pharmaceutical intermediates supply chain optimization and cost efficiency.
Novel glycine-based method for imidazole-4-carboxylates offers high yield and purity, reducing costs for pharmaceutical intermediate manufacturing and supply chains.
Patent CN101597226B reveals a streamlined 2-step synthesis of 6-hydroxy-1-indanone from phenol, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturing.
Patent CN101597226A reveals a novel TfOH-catalyzed cyclization route for 6-hydroxy-1-indanone, offering a streamlined alternative to traditional multi-step amino or methoxy precursor methods for cost-effective manufacturing.
Patent CN104326960A details aqueous synthesis improving purity and yield. Offers supply chain reliability and cost reduction for peptide manufacturing partners globally.
Patent CN101619034B reveals a novel atmospheric pressure method for synthesizing diselenides using elemental selenium and carbon monoxide, offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN113072480A reveals a scalable chemical resolution route for chiral (-)-5-azaspiro[2.4]heptane-7-alcohol, offering superior purity and cost efficiency for API manufacturing.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN109810020B details a mild, high-yield synthesis of cyano-formamides using novel activating reagents, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN105503613B reveals advanced Cu Ni catalyst for polyamine production offering reduced corrosion and enhanced supply chain reliability for global pharmaceutical manufacturers.
Discover the patented Lewis acid-catalyzed preparation of acyl azides. This method offers rapid reaction times, high yields, and significant cost reduction in API manufacturing.
Patent CN112724089B details a high-yield bromination process for 2-amino-3-bromo-6-chloropyrazine, offering significant cost reduction and scalable production for SHP2 inhibitor intermediates.
Patent CN103204845B reveals a recyclable ionic liquid catalyst enabling mild Knoevenagel reactions. Delivers significant cost reduction and supply chain reliability for intermediate manufacturing.
Discover the patented preparation of alpha-chlorinated carbonates for amino acid protection. A breakthrough in cost reduction and scalability for pharmaceutical manufacturing.
Patent CN103570768A reveals a novel chiral cobalt-nitrogen complex enabling efficient Henry reactions, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN109503681B reveals a novel asymmetric synthesis for 2-Fluoro-L-ristosamine. Discover cost-effective manufacturing and reliable supply chain solutions for this critical pharmaceutical intermediate.
Novel patent CN109824547A enables safer synthesis of double protected amino acids. Achieve high purity and reduced costs for pharmaceutical intermediate manufacturing supply chains.
Patent CN100584459C reveals a novel metal-free organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with >99% ee, offering significant cost reduction and supply chain reliability.